China NMPA Drug Inspection - Anhui Bozhou Baolong Company - Typha pollen
China NMPA drug inspection for Anhui Bozhou Baolong Company published October 31, 2019. Drug: Typha pollen. The Hubei Province Drug Administration released findings from its First Round of Drug Sampling Inspections conducted in
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Anhui Bozhou Baolong Company published October 31, 2019. Drug: Typha pollen. The Hubei Province Drug Administration released findings from its First Round of Drug Sampling Inspections conducted in
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
Anhui Bozhou Baolong CompanyInspection Date
Unknown Date
Product Type
ID: 1f7648a6-5fb5-42f3-8a87-d717e57354fc
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox